Neutralizing antibody titres in SARS-CoV-2 infections
BioMed Alliance and 17 other civil society organisations call on policy makers to ensure that the next multiannual EU budget will be fit-for-purpose to address current and future health threats.
Latest Posts
-
-
Breaking newsEAN NewsCOVID-19Research
The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study
The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study -
Breaking newsEAN NewsCOVID-19ResearchParkinson patients’ needs during COVID-19 pandemic in a red zone: a framework analysis of open-ended survey questions
Parkinson patients' needs during COVID-19 pandemic in a red zone: a framework analysis of open-ended survey questions -
Breaking newsEAN NewsCOVID-19Research
The perceived impact of COVID-19 and associated restrictions on young people with epilepsy in the UK: Young people and caregiver survey
The perceived impact of COVID-19 and associated restrictions on young people with epilepsy in the UK: Young people and caregiver survey -
Breaking newsEAN NewsCOVID-19Research
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection -
Breaking newsEAN NewsCOVID-19ResearchImmunological characteristics govern the transition of COVID-19 to endemicity
Immunological characteristics govern the transition of COVID-19 to endemicity -
Breaking newsEAN NewsCOVID-19Research
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape -
Breaking newsEAN NewsCOVID-19ResearchCircuits between infected macrophages and T cells in SARS-CoV-2 pneumonia
Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia -
Breaking newsEAN NewsCOVID-19ResearchLessons from the COVID-19 pandemic for advancing computational drug repurposing strategies
Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategies -
Genetic variants of SARS-CoV-2—what do they mean? -
Breaking newsEAN NewsCOVID-19Research
Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 Patients
Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 Patients -
Adaptive immunity to SARS-CoV-2 and COVID-19
-
Breaking newsEAN NewsCOVID-19Research
MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells
MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells -
Breaking newsEAN NewsCOVID-19Research
Understanding the implications of SARS-CoV-2 re-infections on immune response milieu, laboratory tests and control measures against COVID-19
Understanding the implications of SARS-CoV-2 re-infections on immune response milieu, laboratory tests and control measures against COVID-19 -
Breaking newsEAN NewsCOVID-19Research
SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population
SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population